Clinical Trial Update: Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for paclitaxel albumin-bound as neoadjuvant therapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel Injection (Albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: Jilin University | Conditions: Breast Cancer Stage | Phase 2 | Status: UNKNOWN